Showing results (31-40 of 372) with videos related to
Sort By:
Pageof 38
Current Opinion in Cell Biology|February 17, 2009
Translating biology into clinic: the case of glioblastomaMaddalena Lino, Adrian MerloActa Neuropathologica|January 20, 2004
Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomasMarkus J Riemenschneider, Timmo H Koy, Guido ReifenbergerTargeted Oncology|August 21, 2010
MGMT promoter methylation in malignant gliomasMarkus J Riemenschneider, Monika E Hegi, Guido ReifenbergerBrain Pathology (Zurich, Switzerland)|July 31, 2015
Role of microRNAs Located on Chromosome Arm 10q in Malignant GliomasMarietta Wolter, Thomas Werner, Bastian Malzkorn, et al.Frontiers in Oncology|February 15, 2024
Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cellsRemi Weber, Michael Weller, Guido Reifenberger, et al.Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.Brain Pathology (Zurich, Switzerland)|April 15, 2006
A 21-year-old female with a third ventricular tumorA Martina Messing-Jünger, Markus J Riemenschneider, Guido ReifenbergerNature Communications|June 13, 2015
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modellingMarc Zuckermann, Volker Hovestadt, Christiane B Knobbe-Thomsen, et al.Brain Pathology (Zurich, Switzerland)|November 20, 2009
Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomasDimitri Barski, Marietta Wolter, Guido Reifenberger, et al.Brain Pathology (Zurich, Switzerland)|September 24, 2011
Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targetsBastian Malzkorn, Marietta Wolter, Markus J Riemenschneider, et al.Pageof 38